Home NDC 72606-051 Tocilizumab-anoh
Product NDC 72606-051
11-digit product format 726060051
Labeler code 72606
Product ID 72606-051_bacf86b8-9d2f-45d2-9c35-4f619ea494aa
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name tocilizumab
Dosage form INJECTION, SOLUTION, CONCENTRATE
Route INTRAVENOUS
Labeler CELLTRION USA, Inc.
Application BLA761420
Marketing category BLA
Marketing start 2025-01-26
Substance TOCILIZUMAB
Active strength 162 mg/.9mL
Pharmacologic classes Interleukin 6 Receptor Antagonists [MoA], Interleukin-6 Receptor Antagonist [EPC]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes openFDA label cross-check# Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join AVTOZMA TOCILIZUMAB CELLTRION USA, Inc. 581c288f-8015-40ef-a4c3-683c96db193d 2026-07-27 Boxed warning, Warnings, Adverse reactions Exact identifier application number: BLA761420
DailyMed Product Concepts#
DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 72606-051-01 Tocilizumab-anoh 0.9 mL in 1 SYRINGE, GLASS INJECTION, SOLUTION, CONCENTRATE 0.9 4 72606-051-01 Tocilizumab-anoh 1 in 1 CARTON INJECTION, SOLUTION, CONCENTRATE 1 4 72606-051-02 Tocilizumab-anoh 0.9 mL in 1 SYRINGE, GLASS INJECTION, SOLUTION, CONCENTRATE 0.9 4 72606-051-02 Tocilizumab-anoh 4 in 1 CARTON INJECTION, SOLUTION, CONCENTRATE 4 4 72606-051-03 Tocilizumab-anoh 12 in 1 CARTON INJECTION, SOLUTION, CONCENTRATE 12 4 72606-051-03 Tocilizumab-anoh 0.9 mL in 1 SYRINGE, GLASS INJECTION, SOLUTION, CONCENTRATE 0.9 4 72606-051-04 Tocilizumab-anoh 0.9 mL in 1 SYRINGE, GLASS INJECTION, SOLUTION, CONCENTRATE 0.9 4 72606-051-04 Tocilizumab-anoh 1 in 1 CARTON INJECTION, SOLUTION, CONCENTRATE 1 4 72606-051-05 Tocilizumab-anoh 4 in 1 CARTON INJECTION, SOLUTION, CONCENTRATE 4 4 72606-051-05 Tocilizumab-anoh 0.9 mL in 1 SYRINGE, GLASS INJECTION, SOLUTION, CONCENTRATE 0.9 4 72606-051-06 Tocilizumab-anoh 12 in 1 CARTON INJECTION, SOLUTION, CONCENTRATE 12 4 72606-051-06 Tocilizumab-anoh 0.9 mL in 1 SYRINGE, GLASS INJECTION, SOLUTION, CONCENTRATE 0.9 4
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 72606-051 TOCILIZUMAB-ANOH (TOCILIZUMAB) INJECTION, SOLUTION, CONCENTRATE [CELLTRION USA, INC.] 2 Current NDC, 12 package rows 20250302_60381a7e-d7ae-4384-925d-c19c418d1663.zip
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761420 Avtozma tocilizumab-anoh 351(k) Interchangeable Rx 2026-06-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Exclude flag Status 72606-051-01 72606005101 1 SYRINGE, GLASS in 1 CARTON (72606-051-01) / .9 mL in 1 SYRINGE, GLASS 2025-01-26 No No Historical 72606-051-02 72606005102 4 SYRINGE, GLASS in 1 CARTON (72606-051-02) / .9 mL in 1 SYRINGE, GLASS 2025-01-26 No No Historical 72606-051-03 72606005103 12 SYRINGE, GLASS in 1 CARTON (72606-051-03) / .9 mL in 1 SYRINGE, GLASS 2025-01-26 No No Historical 72606-051-04 72606005104 1 SYRINGE, GLASS in 1 CARTON (72606-051-04) / .9 mL in 1 SYRINGE, GLASS 2025-01-26 No No Historical 72606-051-05 72606005105 4 SYRINGE, GLASS in 1 CARTON (72606-051-05) / .9 mL in 1 SYRINGE, GLASS 2025-01-26 No No Historical 72606-051-06 72606005106 12 SYRINGE, GLASS in 1 CARTON (72606-051-06) / .9 mL in 1 SYRINGE, GLASS 2025-01-26 No No Historical